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Abstract	 SA Fam Pract 2010;52(5):471-475
Background: The danger of poor adherence to treatment by patients with HIV infection is that poor adherence correlates 
with clinical and virological failure. Understanding how private-sector doctors monitor adherence by their HIV-infected 
patients could assist in developing interventions to improve adherence by these patients. Information about such practices 
amongst private-sector doctors in the province of KwaZulu-Natal, however, is limited. This study was, therefore, undertaken 
to assess the private-sector doctor adherence-monitoring practices of HIV-infected patients in the eThekwini metro of 
KwaZulu-Natal.
Methods: A descriptive cross-sectional study was undertaken amongst private general practitioners (GPs) and specialists 
managing HIV/AIDS patients in the eThekwini metro. Anonymous semi-structured questionnaires were used to investigate 
adherence-monitoring practices by these doctors and their strategies to improve adherence.
Results: A total of 171 doctors responded, with over 75% in practice for over 11 years and 78.9% indicating that they 
monitored adherence. A comparison between the GPs and the specialists found that 82.6% of the GPs monitored 
adherence compared with 63.6% of the specialists (p = 0.016). The doctors used several approaches, with 60.6% reporting 
the use of patient self-reports and 18.3% reporting the use of pill counts. A total of 68.7% of the doctors indicated that their 
adherence monitoring was reliable, whilst 19.7% indicated that they did not test the reliability of their monitoring tools .The 
most common strategy used to improve adherence by their patients was through counselling. Other strategies included 
alarm clocks, SMSs, telephone calls to the patients, the encouragement of family support and the use of medical aid 
programmes.
Conclusions: Private-sector doctors managing HIV/AIDS patients in the eThekwini metro of KwaZulu-Natal do monitor 
adherence and employ strategies to improve adherence.
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Introduction
The success of antiretroviral (ARV) therapy (ART) is 
highly dependent on the ability of the patient to adhere 
to prescribed treatment regimens.1 The advent of highly- 
active ARV therapy (HAART) ushered in a new era in the 
management of the HIV/AIDS pandemic with new drugs, 
new strategies and enthusiasm from clinicians and patients. 
What soon became evident, however, was the vital 
importance of patient adherence to prescribed medication 
to obtain full therapeutic benefits.2 Adherence is associated 
with patient factors, the regimen, the clinical setting and the 
strength of the provider-patient relationship3 and is an equal 
partnership between the patient and her or his healthcare 
provider.4
Various factors are associated with poor adherence, 
including the following: low levels of literacy; certain age-
related challenges (such as vision loss and cognitive 
impairment); psychosocial issues (such as depression, 
homelessness, lower social support, stressful life events, 
dementia and psychosis); active (but not a history of) 
substance abuse, particularly for patients experiencing 
recent relapse; stigma; difficulty with the taking of the 
medication (such as trouble swallowing the pills and daily 
schedule issues); complex regimens (such as pill burden, 
dosing frequency and food requirements); adverse drug 
effects; and treatment fatigue.5-8 For chronic conditions, 
long-term and sometimes complex regimens make it critical 
for adherence to be sustained over time. In HIV-infected 
persons, non-adherence to ART is shown to be one of 
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the most important predictors of therapeutic failure.9 The 
danger of poor adherence by patients with HIV infection is 
that poor adherence correlates with clinical and virological 
failure.10
Information provided by health professionals and patient 
understanding about HIV infection and their specific ARV 
regimens are critical. Patients who understand the rationale 
for ART and the role of adherence in the development of 
resistance and treatment failure report higher adherence 
levels than those without this information.11 Patient non-
adherence can take many forms, since the advice given 
to patients by their healthcare professionals to cure or 
control the disease is too often misunderstood or carried 
out incorrectly, forgotten or even completely ignored.12 
Reinforcement by health professionals of information 
provided verbally, together with written information to 
take home, and checking that the information provided is 
understood are important in cases where the information is 
normally misunderstood by the patients.
One study found that 13% of the patients were not taking 
their medication properly despite believing that they were.11 
A South African study done in a managed healthcare 
setting, however, found that 31.1% of the doctors failed to 
note non-adherence as a cause of treatment failure.13
Various factors affect adherence to ART and it is, 
therefore, important for healthcare providers to explore 
these factors and to foster a trusting relationship before 
offering therapy, so that the success of treatment can be 
maximised. Numerous medication alert strategies, such as 
programmable watches and SMS text messaging, play an 
important role in patients who cite forgetfulness as a reason 
for missing their medication.11 Other strategies, such as 
telephone reminders, pill diaries and counts, medication 
containers and the enlistment of family and friends as 
reminders, have also been shown to improve adherence in 
other disease areas.11
A study done in KwaZulu-Natal amongst private-sector 
doctors concluded that client motivation and close 
relationships with their providers were crucial to the success 
of the programmes,14 whilst another study found that 
experienced physicians achieved better patient adherence.15 
The average rate of adherence varied according to the 
methods used to assess adherence and the groups studied, 
but appeared to be approximately 70%.16-18
An understanding of how private-sector doctors monitor 
adherence to treatment by their HIV-infected patients and 
of the strategies that they use to improve adherence could 
assist in developing interventions to improve adherence 
by these patients. Information about such practices in 
the province of KwaZulu-Natal is, however, limited or 
even lacking. This study was, therefore, undertaken to 
assess the private-sector doctor adherence-monitoring 
practices of HIV-infected patients in the eThekwini metro of 
KwaZulu-Natal.
Methods
Study design, study site and sample population
A descriptive cross-sectional study was undertaken in the 
eThekwini metro of KwaZulu-Natal. A comprehensive list of 
1 255 general practitioners (GPs) and specialists practising 
in the eThekwini metro was obtained from the Medpages 
Directory, the KwaZulu-Natal Managed Care Coalition (a 
private-doctor group), doctors’ guilds, the Lancet Clinic 
Courier database and the Southern African HIV Clinicians 
Society. Some of the specialist doctors were excluded after 
they indicated that their contact with HIV/AIDS patients was 
minimal and felt that it would, therefore, be inappropriate 
for them to participate. These included gynaecologists, 
surgeons, occupational health doctors, psychiatrists, 
cardiologists, anaesthetists, ophthalmologists, plastic 
surgeons, critical care doctors and doctors working in the 
trauma units of private hospitals.
The study was divided into two phases. Phase 1 included 
235 doctors who indicated that they managed HIV and 
AIDS patients, 190 of whom indicated their willingness 
to participate in Phase 2.19 These doctors were surveyed 
by using semi-structured questionnaires after obtaining 
their consent. The questionnaires were coded so that no 
identification would be possible and to ensure anonymity 
and confidentiality. The study was undertaken in the 
province of KwaZulu-Natal, since this is the province with 
the largest provincial population in South Africa, with just 
over 10 million people (20.9% of the total population of 47.9 
million),20 and it is the province with the highest prevalence 
of HIV, as indicated by antenatal clinic attendee data (39.1% 
in 2006, with the national figure being 29.1%).21
The study included data on the demographic profiles of 
the doctors, their adherence-monitoring practices, the 
type of adherence-monitoring tools that they used and the 
strategies that they employed to improve adherence by their 
HIV/AIDS patients. These took the form of closed-ended 
questions. Most of the questionnaires were hand-delivered 
and collected on completion. A few of the questionnaires 
were faxed and, when completed, were faxed back.
The data were captured and analysed with the SPSS 
version 15.0. Pearson chi square was used to determine 
the p value. A p value of less than 0.05 was considered 
statistically significant.
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Ethics clearance
Approval to conduct the study was obtained from the 
Nelson R Mandela School of Medicine, Faculty of Medicine, 
College of Health Science, University of KwaZulu-Natal. The 
ethics number is H138/03.
Results
Demographic data
A total of 171 doctors responded, 138 (80.7%) of whom 
were GPs and the majority of whom were males. A total of 
67% (108) of the respondents was in the age range of 30 to 
50 years and over 75% of the doctors had been in practice 
for over 11 years.
Adherence-monitoring practices
Of the private-sector doctors who responded, 78.9% 
indicated that they monitored adherence.
A comparison between the GPs and the specialists showed 
that 82.6% of the GPs monitored adherence, whilst about 
two-thirds (63.6%) of the specialists monitored adherence 
(p = 0.016).
The doctors used several approaches to monitor adherence 
(Figure 1), with the majority of them (60.6%) reporting the 
use of patient self-reports compared with only 18.3% 
reporting the use of pill counts as a means of monitoring 
adherence.
A comparison between the GP and the specialist use of 
monitoring tools (Table I) showed a significant result for 
adherence monitoring by pill count. A similar percentage of 
the GPs and specialists, however, used laboratory markers, 
such as CD4 counts and viral load, to monitor adherence.
Of the respondents who monitored adherence, 68.7% 
indicated that their adherence monitoring was reliable, 
11.6% indicated that their adherence monitoring was not 
reliable and 19.7% indicated that they did not test the 
reliability of their adherence monitoring tools.
Strategies to improve adherence
The most common strategy used by doctors to improve 
adherence by their patients was educating patients, which 
they did by talking to them. This was indicated by 71.2% 
of the doctors, who indicated that they always or often 
counselled their patients on adherence, the state of their 
disease, side effects, nutrition, various types of interactions 
to alcohol abuse and complementary medicines. A total of 
96.4% of the GPs and 93.9% of the specialists indicated 
that it was not time-consuming to counsel their patients.
Other strategies used by fewer of the doctors to improve 
adherence by their patients included the use of alarm clocks 
(14.2%) and SMSs (9.5%), whilst others (7.1%) phoned their 
patients, encouraged family support and used medical-aid 
programmes.
Discussion
The respondents in this study used many strategies to 
monitor adherence, such as self-reports, CD4 counts, viral 
loads, doctor estimates, refills, side effects and pill counts, 
with just over two-thirds considering their monitoring tools 
to be reliable. Doctors managing HIV-infected patients 
should have an accurate and relatively simple method of 
monitoring adherence to ensure good clinical outcome. 
It is well known that provider estimates of adherence are 
inaccurate and often lead to the incorrect assumption of 
good adherence.16 Several strategies to monitor adherence 
exist, including pill counts, electronic monitors and self-
report questionnaires. The methods used to monitor 
adherence, however, have both strengths and weaknesses 
and can yield widely varying results.22,23 Patient self-
reports seemed to be used by the majority of the doctors 
in this study. Even though this is a relatively simple and 
efficient method of assessing adherence in clinical practice 
compared with objective measures, such as micro electro-
mechanical systems (MEMS) caps and unannounced pill 
counts, self-assessment is a less sensitive measure of non-
adherence, since patients tend to overestimate adherence 
when self-reporting, while electronic monitoring can be an 
inaccurate measure of non-adherence, since patients can 
Table I: Comparison of GP and specialist adherence-monitoring tools
Monitoring tool N GPs Specialists Total P value
Pill count 169 29 (21.3%) 2 (6.1%) 31 (18.3%) 0.042
CD4 170 75 (54.7%) 16 (48.5%) 91 (53.5%) 0.517
Viral load 170 63 (46.0%) 14 (42.4%) 77 (45.3%) 0.712
Refill 169 43 (31.6%) 6 (18.2%) 49 (29.0%) 0.127
Estimate 169 35 (25.7%) 6 (18.2%) 41 (24.3%) 0.364
Side effects 169 34 (25.0%) 4 (12.1%) 38 (22.5%) 0.112
Self-report 170 86 (62.8%) 17 (51.5%) 103 (60.6%) 0.235
Figure 1: Tools used by private-sector doctors to monitor adherence in the
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remove multiple doses at a single time or not take a dose 
when it is removed.22,24 Many of the adherence-monitoring 
methods are also limited in that they fail to detect non-
adherence related to not following dietary restrictions or 
dosing intervals.22 There is thus no gold standard by which 
to monitor adherence.
To assess adherence accurately, clinicians should develop 
a collaborative and non-judgmental relationship with their 
patients. The best strategy when asking patients about 
their adherence is not in the specifics of the tool used but in 
taking the time to enquire regularly about adherence in an 
open manner. Many patients otherwise simply respond by 
what they believe their clinicians want to hear, namely that 
they have been perfectly adherent.16 A trilogy of information, 
motivation and behavioural skills is essential in ensuring 
adherence to HAART.25
Laboratory markers, such as CD4 counts and viral loads, 
were also used by the respondents to monitor adherence. 
The main goal of ART is to prevent HIV-related morbidity 
and mortality and many studies have shown a strong 
correlation between adherence and clinical outcomes and/
or laboratory markers (notably CD4 counts).16 Adherence 
is associated with CD4 counts, as demonstrated by one 
study in which respondents who had adherence equal to or 
greater than 95% had a mean increase in their CD4 count 
of 83 cells/µl compared with those with a less than 95% 
adherence level, who had a mean increase of 6 cells/µl.10 
Whilst another study done amongst Brazilian HIV-infected 
patients concluded that, although self-reported adherence 
was not a sufficiently precise predictor of treatment success 
to substitute for viral-load monitoring, it did help to identify 
non-adherence, thereby providing an opportunity for early 
intervention.1 In addition, in a study done in Uganda with 
self-paying patients who were followed for 90 days after the 
initiation of ART, mean adherence measured through 3-day 
self-reports, 30-day self-reports, unannounced pill counts 
and MEMS caps was found to be 92.9%, 91.6%, 91.9% 
and 90.35%, respectively.26
Patient education about the multifaceted aspects of ART is a 
crucial component of care.27 In this study, the doctors used 
many strategies to improve adherence, with over 70% of 
the doctors emphasising the importance of educating their 
patients to improve adherence. The doctors counselled their 
HIV-infected patients on a wide range of topics relevant to 
adherence, thereby enforcing the information and education 
to improve their knowledge about their drug therapy and 
disease state. The topics varied from counselling on 
adherence, disease state, side effects, nutrition, various 
types of interactions to alcohol abuse and complementary 
medicines. The vast majority of the doctors indicated that 
time was not an issue when it came to counselling their HIV-
infected patients.
Extensive counselling, especially for patients who are non-
adherent, can be very time-consuming but, with over 93% 
of the doctors stating that it was not time-consuming to 
counsel, questions on the quality of counselling sessions 
should be raised. Interventions to improve ARV adherence 
involve dedicated time with patients to plan for and 
support medication adherence with effective interventions 
characterised by an initial educational session, including 
individualised collaborative medication planning with 
follow-up sessions maintained regularly over the course of 
treatment.16 With the limited time sometimes available for 
doctor-patient consultation and with the availability of other 
skilled allied professionals, doctors could work towards 
a multidisciplinary approach to HIV care. Nurse-led and 
pharmacist-led programmes, for example, show improved 
virological response and adherence levels, respectively, in 
people receiving HAART.11
Other strategies, such as alarm clocks and SMSs, were used 
by fewer of the doctors. It would be prudent for doctors, 
however, to encourage the use of devices that help patients 
to adhere to their treatment regimens, such as pill boxes 
and reminder devices. Most of them are simple, inexpensive 
and easy to integrate into the routine care of patients on 
ART. Patients taking pill boxes to appointments can help 
clinicians to monitor for recent non-adherence. Reminder 
devices, such as alarms on watches and cell phones, 
SMSs, beepers or any other electronic reminder devices, 
are especially important for patients who forget to take their 
medicine. A small minority of doctors in this study stated 
that they phoned their patients and encouraged family 
support to improve adherence by their patients. These 
practices should be encouraged as a means of improving 
adherence to the treatment of HIV-infected patients.11
Conclusions	and	recommendations
The private-sector doctors in this study who manage HIV 
and AIDS patients do monitor for adherence using different 
monitoring tools, although the reliability of the tools has not 
been assessed by all the doctors. They do have strategies 
to improve adherence by their patients, but they should do 
more in this area.
Doctors have an important role in motivating and 
supporting their patients to adhere to ARV treatment. They 
should ensure that their patients are well educated and 
counselled about their disease state and management. 
Adherence to management can be effectively monitored 
by doctors if good therapeutic relationships are developed 
with the patients. A combination of methods appropriate 
to the patients and clinical settings should also be used 
to improve adherence. Adherence interventions should 
include dedicated educational sessions with every patient 
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and a programme of providing the necessary support in an 
open and non-judgmental manner throughout the course 
of treatment. In this way, problems can be addressed 
and adherence devices supplied or recommended where 
appropriate.
Limitations
The findings of this study should be interpreted in the light of 
its limitations. This was a cross-sectional study and there is 
thus not strong evidence of causal relationship. The size of 
the sample and the sampling method used do not allow for 
the findings to be generalised to all private-sector doctors 
practising in the eThekwini metro of KwaZulu-Natal. Finally, 
the validity of data could be reduced because of this being 
a self-reported questionnaire survey.
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